• Resources
    • Videos/Speeches/Articles
    • The Art of Health Freedom
    • Good Books
    • Recommended Videos
    • Recommended Links
    • Radio Show Archives
    • Trustee Interviews
    • Newsletter Archives
    • Internet Links
  • Rave Reviews
    • Testimonials
    • Video Testimonials
  • Take Action
    • Create Pushback
    • Tell Your Friends
    • Become an Organizer
    • Send Letters
  • Wellness Stores
    • Buy our products
    • Valley of the Moon Coffee
  • 5 Big Lies
    • Drugs & Vaccine
    • Chemtrails
    • G.M.O.
    • Radiation
    • Food
  • Home
  • Support
    • Support Health Freedom
    • Coffee
  • Events/Press/Media
    • POD Casts/Radio Shows
    • Webinars
    • Press Release
  • About Us
    • Mission Statement
    • Accomplishments
    • Board of Trustees
    • NSF History/Vision
    • Contact Webmaster
    • Customer Service
  • Dr. Rima’s Blog/Vlog
    • GDS
    • Codex Alimentarius
  • eBook Download

Let the House Cleaning Begin, and Let the Lethal Games End!

By Administrator on October 25, 2006 1 Comments

The FDA is one of the most highly corrupted and corrupting organizations on the planet. Charged with food, drug and cosmetic safety, what has been protected is the financial safety of corporate profits with the tickle-down effect firmly in place: regulators and panel members get rich quick through lucrative, unethical and often illegal stock deals, stock options, family financial hanky panky and a host of variations on the theme.

Perhaps you remember the advisory panel of experts that put Vioxx back on the market despite at LEAST 55 thousand deaths in the US alone (perhaps as many as 188 thousand, according to some). The members of that panel had a majority of experts on it who owned stock and had other financial interests in Merck and related corporations. They overruled previously presented advice by people who did NOT have financial interests to allow Vioxx back on the market. Shortly thereafter they approved Vioxx for children!

But perhaps things are getting better. Lester Crawford, who served as the acting Commissioner of the FDA for over a year before his confirmation in 2005 suddenly left his post — suddenly, as in during the course of a single day. His reason? Spending time with the family, of course. The real reason? Illegal stock dealings. Could this be the beginning of a house cleaning? Let’s hope so. The Institute of Medicine says that the FDA is broken. It certainly is. What broke it is the corruption of too much money buying too much influence.

The Institute of Medicine released a study on the safety of pharmaceuticals which was a damning condemnation of the FDA.  Coming from the same organization which supports the status quo in a report that says there is no link between autism and mercury (http://www.fda.gov/fdac/features/2004/504_iom.html) this is a stinging criticism, indeed.  The IOM says the FDA cannot be trusted and is, frankly, broken. In placid, cool bureaucratic tones, here is the scathing abstract of that report in the IOM’s words:

In response to growing public concern with health risks posed by approved drugs, U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services announced a series of steps to address drug safety, including asking the IOM to convene a committee to assess the U.S. drug safety system and to make recommendations to improve risk assessment, surveillance, and the safe use of drugs.In its report, The Future of Drug Safety: Promoting and Protecting the Health of the Public, the committee considered the drug safety system as the sum of all activities conducted by FDA and other stakeholders to monitor, evaluate, improve, and ensure drug safety.

Although much of the committee’s work was focused around the drug review, safety surveillance, and related activities of the Center for Drug Evaluation and Research (CDER), the committee also reviewed some key aspects of the roles and considered the potential contributions of the pharmaceutical industry, the academic research enterprise, Congress, the health care delivery system, patients and the public.

During its research, the committee found that

  1. There is a perception of crisis that has compromised the credibility of FDA and of the pharmaceutical industry.
  2. Most stakeholders–the agency, the industry, consumer organizations, Congress, professional societies, health care entities–appear to agree on the need for certain improvements in the system.
  3. The drug safety system is impaired by the following factors: serious resource constraints that weaken the quality and quantity of the science that is brought to bear on drug safety; an organizational culture in CDER that is not optimally functional; and unclear and insufficient regulatory authorities particularly with respect to enforcement.
  4. FDA and the pharmaceutical industry do not consistently demonstrate accountability and transparency to the public by communicating safety concerns in a timely and effective fashion.

Noting that resources and therefore efforts to monitor medications’ risk-benefit profiles taper off after approval, the committee that wrote the report offered a broad set of recommendations to ensure that consideration of safety extends from before product approval through the entire time the product is marketed and used.

Recommendations include:

  • Labeling requirements and advertising limits for new medications
  • Clarified authority and additional enforcement tools for the agency
  • Clarification of FDA’s role in gathering and communicating additional information on marketed products’ risks and benefits
  • Mandatory registration of clinical trial results to facilitate public access to drug safety information
  • An increased role for FDA’s drug safety staff
  • A large boost in funding and staffing for the agency


Part of that failure, of course, is a failure of leadership.  Lester Crawford is not unique in his corruption.  He is unique in that his corruption (or a small piece of it?) has been publicly exposed.  Here is Pete Yost’s story on Crawford’s corruption:

Ex-FDA Chief to Plead Guilty
By PETE YOST
The Associated Press
Monday, October 16, 2006; 6:44 PM
WASHINGTON — Former FDA chief Lester Crawford has agreed to plead guilty to charges of failing to disclose a financial interest in PepsiCo Inc. and other firms regulated by his agency, his lawyer said Monday.
The Justice Department accused the former head of the Food and Drug Administration in court papers of falsely reporting that he had sold stock in companies when he continued holding shares in the firms governed by FDA rules.
Court papers say Crawford chaired the Food and Drug Administration’s Obesity Working Group while he and his wife owned shares worth at least $62,000 in soft drink and snack food manufacturer Pepsico Inc., based in Purchase, N.Y. In addition, the documents say, he held stock worth at least $78,000 in food product manufacturer Sysco Corp., based in Houston.
While he and his wife owned the stock, the panel Crawford chaired met with representatives from the packaged food industry and gave congressional testimony encouraging manufacturers to relabel serving sizes to give calorie counts greater prominence.
Crawford “is going to plead guilty to two misdemeanors tomorrow afternoon and he is going to admit his financial disclosures had errors and omissions, mostly with his wife’s continued ownership of stocks,” said Crawford’s lawyer, Barbara Van Gelder.
“At the end of the day, he owned these stocks and he will admit he owned them while he was at the FDA and he will take responsibility for that,” said Van Gelder. She said Crawford was not disputing the government’s claims in what she called a plea agreement.
Accused of making a false writing and conflict of interest, Crawford was scheduled to appear before a federal magistrate Tuesday afternoon. Each charge carries a maximum penalty of one year in prison.
The papers say Crawford failed to disclose his income from exercising stock options in Embrex Inc. of Research Triangle Park, N.C., an agriculture biotechnology company that has been regulated by FDA. Crawford had been a member of Embrex’s board of directors, according to federal filings.
Crawford, a veterinarian, abruptly resigned from the FDA in September 2005 but gave no reason for his departure. He had held the top position for just two months but had been acting head of the agency for more than a year.
According to the Justice Department’s court papers:
_A government ethics official inquired about Crawford’s ownership of stock in several companies FDA regulates and Crawford replied in a Dec. 28, 2004, e-mail that “Sysco and Kimberly-Clark have in fact been sold.” Actually, the court papers state, Crawford knew that he or his wife still held shares in both.
_Even though financial reporting requirements for federal officials say all income must be disclosed, Crawford failed to reveal $8,000 in income from the exercise of Embrex stock options in 2003, and failed to report $20,000 from the sale of Embrex stock options in 2004.
Crawford’s ownership of shares in Pepsico, Sysco, Embrex and the other companies was prohibited under federal regulations, since the companies are considered to be “significantly regulated” by the FDA.
___
AP reporter Andrew Bridges contributed to this story.
© 2006 The Associated Press
Of course, the current “leadership” of the FDA, in positions 1 and 2 are industry men, through and through.  Will the outrages, deaths and betrayals of the American people have to get worse before the house is really cleaned by an outraged Congress acting on the outrage of its citizens?  Let’s hope not.   
Categories : Blog / Vlog, The Law & CODEX

Leave a Reply

Click here to cancel reply.

You must be logged in to post a comment.

Sign Up Form

Search

Breaking News

  • Remembering General Bert
  • Crisis Standards of Care
  • Health Keepers: Remember Your Oath!
  • Racism, Reaction and Rights
  • We’re Back!
  • Attacked! Attacked! List Terminated Without Notice
  • Dr. Rima’s End of Year Podcast
  • Another State About to Abrogate Religious Conscientious Objection
  • “Flu Season” – Is YOUR Immune System Ready?
  • FDA at It Again: Attacking Compounding Pharmacies

Popular Posts:

  • Advance Vaccine Directive:I Do Not Consent! 156,225 views
  • Meet Rima E. Laibow, M.D. 122,188 views
  • 404 Error: Page Not Found 109,510 views
  • Founders of Natural Solutions Foundation 82,535 views
  • About the Natural Solutions Foundation, Its Trustees and Advisers 80,095 views
  • 5 Big Lies: Drugs & Vaccines 58,203 views
  • Resources – Books & Links 52,164 views